GSK PLC (GSK)
33.62
+0.27
(+0.81%)
USD |
NYSE |
Nov 21, 13:30
GSK Price: 33.62 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 33.40 | 33.53 | 33.19 | 33.35 | 7.492M |
| Nov 19, 2024 | 33.28 | 33.60 | 33.23 | 33.46 | 8.988M |
| Nov 18, 2024 | 33.29 | 33.79 | 33.25 | 33.69 | 8.802M |
| Nov 15, 2024 | 33.26 | 33.50 | 32.82 | 33.35 | 13.75M |
| Nov 14, 2024 | 35.40 | 35.46 | 34.36 | 34.39 | 7.033M |
| Nov 13, 2024 | 35.17 | 35.29 | 34.81 | 35.11 | 7.279M |
| Nov 12, 2024 | 35.50 | 35.63 | 35.25 | 35.52 | 7.246M |
| Nov 11, 2024 | 36.55 | 36.74 | 36.32 | 36.35 | 5.054M |
| Nov 08, 2024 | 36.12 | 36.42 | 36.10 | 36.29 | 8.867M |
| Nov 07, 2024 | 36.23 | 36.73 | 36.14 | 36.66 | 14.93M |
| Nov 06, 2024 | 35.93 | 36.14 | 35.62 | 35.90 | 14.28M |
| Nov 05, 2024 | 36.70 | 37.05 | 36.48 | 37.02 | 7.088M |
| Nov 04, 2024 | 37.03 | 37.26 | 36.94 | 36.97 | 3.995M |
| Nov 01, 2024 | 37.59 | 37.60 | 36.85 | 36.88 | 6.877M |
| Oct 31, 2024 | 36.27 | 37.01 | 36.07 | 36.76 | 12.12M |
| Oct 30, 2024 | 36.50 | 37.23 | 36.28 | 37.01 | 13.42M |
| Oct 29, 2024 | 37.94 | 38.26 | 37.88 | 38.17 | 6.141M |
| Oct 28, 2024 | 37.70 | 38.08 | 37.67 | 37.88 | 4.112M |
| Oct 25, 2024 | 37.95 | 38.00 | 37.43 | 37.52 | 3.375M |
| Oct 24, 2024 | 38.03 | 38.19 | 37.66 | 37.74 | 4.666M |
| Oct 23, 2024 | 37.74 | 37.99 | 37.65 | 37.98 | 4.866M |
| Oct 22, 2024 | 37.72 | 38.04 | 37.72 | 38.00 | 3.890M |
| Oct 21, 2024 | 38.49 | 38.51 | 38.08 | 38.16 | 2.873M |
| Oct 18, 2024 | 38.80 | 38.84 | 38.38 | 38.55 | 3.727M |
| Oct 17, 2024 | 39.21 | 39.24 | 38.92 | 38.96 | 4.991M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
28.66
Minimum
Sep 27 2022
48.75
Maximum
Jan 17 2020
39.47
Average
39.53
Median
Jan 22 2024
Price Benchmarks
| AstraZeneca PLC | 63.88 |
| Pfizer Inc | 25.12 |
| Sanofi SA | 48.01 |
| Moderna Inc | 38.48 |
| Autolus Therapeutics PLC | 2.85 |
Price Related Metrics
| PE Ratio | 21.86 |
| PS Ratio | 1.746 |
| Price to Book Value | 3.659 |
| Price to Free Cash Flow | 11.45 |
| Earnings Yield | 4.58% |
| Market Cap | 68.59B |
| Operating PE Ratio | 12.23 |
| Normalized PE Ratio | 18.65 |